Organization
Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan
7 abstracts
Abstract
Upfront allo-HSCT after intensive chemotherapy for untreated aggressive ATL: JCOG0907, a single-arm, phase 3 trial.Org: Department of Health Sciences, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan, Saitama Medical University, Hidaka-Gun, Japan, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, National Cancer Center Hospital, Tokyo, Japan, National Cancer Center Hospital, Chuo-Ku, Japan,
Abstract
Final results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306.Org: Department of Advanced Medical Sciences, Oita University, Yufu, Japan, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Division of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan,
Abstract
The subgroup analysis by age and geriatric assessment in a phase III study comparison of trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in older patients with advanced stage HER2-positive breast cancer (JCOG1607 HERB TEA study).Org: National Center for Global Health and Medicine, Shimane University Hospital, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan,
Abstract
ctDNA monitoring for breast cancer at high risk of recurrence: Interim analysis of JCOG1204A1.Org: Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan, Breast Medical Oncology Department, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan, National Defense Medical College Hospital, Tokorozawa, Japan, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, Department of Breast Care, Saitama Medical Center, Saitama, Japan,
Abstract
A confirmatory trial of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumor diameter preoperatively estimated at 2 cm or less: Japan Clinical Oncology Group study, JCOG1101.Org: Toranomon Hospital, Tokyo Metropolitan Bokutoh Hospital, Radiation Therapy Center, Okinawa Chubu Hospital, Kagoshima University Hospital,
Abstract
A risk prediction model for cisplatin-induced acute kidney injury in head and neck cancer patients who receive chemoradiotherapy: A supplement analysis of a phase II/III trial of JCOG1008.Org: Kobe University Hospital, Kobe, Hyogo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa-Shi, Aichi Cancer Center Hospital, Jichi Medical University Hospital,
Abstract
Impact of acute kidney injury on overall survival in postoperative patients with head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of a phase II/III trial of JCOG1008.Org: Kobe University Hospital, Kobe, Hyogo, Japan, National Cancer Center Hospital East, Kashiwa, Chiba, Japan, Aichi Cancer Center Hospital, Nagoya, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Jichi Medical University, Shimotsuke-Shi, TOCHIGI-KEN, Japan,